Michal Koutny

Michal Koutny, FCCA, currently serves as Executive Director Finance at Swixx BioPharma since March 2024. Prior experience includes a tenure at Ipsen from April 2019 to February 2024, where Michal held multiple roles including Finance Director for Ipsen DACH and Head of Finance for International Clusters and China. Before Ipsen, Michal worked at Bristol-Myers Squibb from February 2005 to March 2019, progressing through various finance leadership positions, such as Finance Director for the Intercontinental Region HQ and South East Asia Cluster. Initial experience included a role as Management Accountant Assistant at Unilever from May 2003 to February 2005. Michal Koutny holds a Master's degree in Finance from VSB - Technical University of Ostrava and is a member of ACCA.